Treatment of prostate cancer with combination of abiraterone acetate and niraparib

The present disclosure relates to combinations of abiraterone acetate and niraparib, free dose combinations and fixed dose combinations of abiraterone acetate and niraparib, and methods of treating prostate cancer with such combinations. 本披露涉及醋酸阿比特龙和尼拉帕尼的组合、醋酸阿比特龙和尼拉帕尼的自由剂量组合和固定剂量组合、以及用所述组合治疗前列腺癌的方法...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	QUINTEN TOBY RENE AUGUST, BERTELS JENS, DELAET, URS, A., C, MARCOCCHI TOMMASO, LUIJTEN KEES, LOPEZ-GITELIZ ALBERTO, HAINES PAUL EUGENE HAROLD, TAMBUVEKAR KEYUR RAVINDRA, HARTMAN KOK, PETER, J., A
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to combinations of abiraterone acetate and niraparib, free dose combinations and fixed dose combinations of abiraterone acetate and niraparib, and methods of treating prostate cancer with such combinations. 本披露涉及醋酸阿比特龙和尼拉帕尼的组合、醋酸阿比特龙和尼拉帕尼的自由剂量组合和固定剂量组合、以及用所述组合治疗前列腺癌的方法。